# OnCo record nct02665065 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02665065/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02665065", "NCT02665065" ;
  schema:name "Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia"@en ;
  schema:alternateName "SIERRA"@en ;
  schema:description "A phase 3 trial of Iomab-B run by Actinium Pharmaceuticals, active."@en ;
  schema:url <https://onco.cc/trials/nct02665065/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02665065> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2016-06" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-older-unfit/> ;
  onco:technologies <https://onco.cc/technologies/radioimmunotherapy/>, <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:drugs <https://onco.cc/drugs/iomab-b/> ;
  onco:companies <https://onco.cc/companies/actinium-pharmaceuticals/> .